Home › Kanser sa Traktong Biliary › California › Los Angeles
Pag-aaral pangklinika para sa Kanser sa Traktong Biliary sa Los Angeles, CA
Isang pag-aaral para sa Kanser sa Traktong Biliary ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Los Angeles. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
A Study of Rilvegostomig or Durvalumab Plus Chemotherapy for First-Line Treatment of Biliary Tract Cancer (ARTEMIDE-Biliary02)
Nagre-recruitPhase 3
- Research Site, Los Angeles
Spevatamig (PT886) as Monotherapy or in Combination With Chemo and/or Targeted Therapy and/or ICI, for the Treatment of Patients With Advanced Gastrointestinal Cancers, Including Gastric, Gastroesophageal Junction, Pancreatic Ductal or Biliary Tract Carcinomas (the TWINPEAK Study)
Nagre-recruitPhase 1/2
- USC Norris Comprehensive Cancer Center, Los Angeles
A Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A)
Nagre-recruitPhase 1/2
- UCLA ( Site 0317), Los Angeles
Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
Nagre-recruitPhase 2
- Research Site, Los Angeles
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
Nagre-recruitPhase 1
- START - Los Angeles, Los Angeles
- Cedars Sinai, Los Angeles
AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
Nagre-recruitPhase 1/2
- Avenzo Therapeutics Recruiting Site, Los Angeles
- Avenzo Therapeutics Recruiting Site, Los Angeles
Phase 3 Study of T-DXd and Rilvegostomig Versus SoC in Advanced HER2-expressing Biliary Tract Cancer
Nagre-recruitPhase 3
- Research Site, Los Angeles
- Research Site, Los Angeles
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
Nagre-recruitPhase 1/2
- Los Angeles Cancer Network, Los Angeles
A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
Nagre-recruitPhase 1
- Cedars-Sinai Medical Center, Los Angeles
Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes
Nagre-recruit
- Cedars-Sinai Medical Center, Los Angeles
A Study of MT-4561 in Patients With Various Advanced Solid Tumors
Nagre-recruitPhase 1/2
- University of Southern California, Los Angeles
Pag-aaral para sa Kanser sa Traktong Biliary sa ibang lungsod
- Houston, TX18 pag-aaral
- Boston, MA11 pag-aaral
- New York City, NY10 pag-aaral
- Nashville, TN9 pag-aaral
- Baltimore, MD8 pag-aaral
- San Antonio, TX8 pag-aaral
- Washington, DC7 pag-aaral
- Pittsburgh, PA7 pag-aaral
- Arlington, VA7 pag-aaral
- Madison, WI6 pag-aaral
- Cleveland, OH6 pag-aaral
- Dallas, TX6 pag-aaral
Iba pang pag-aaral sa Los Angeles
- Non-Small Cell Lung Cancer87 pag-aaral
- Kanser (lahat ng uri)74 pag-aaral
- Kanser sa Suso73 pag-aaral
- Kanser sa Prostate61 pag-aaral
- Colorectal Cancer59 pag-aaral
- Metastatic Cancer57 pag-aaral
- Kanser sa Ovary50 pag-aaral
- Kanser sa Baga45 pag-aaral
- Squamous Cell Carcinoma ng Ulo at Leeg42 pag-aaral
- Kanser sa Pancreas35 pag-aaral
- Kanser ng Endometrium34 pag-aaral
- Melanoma34 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.